• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤患者中的 ALK 胚系突变:一种罕见且弱外显的综合征。

ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.

机构信息

Institut Curie, Département de pédiatrie, Paris, France.

出版信息

Eur J Hum Genet. 2012 Mar;20(3):291-7. doi: 10.1038/ejhg.2011.195. Epub 2011 Nov 9.

DOI:10.1038/ejhg.2011.195
PMID:22071890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3283184/
Abstract

Neuroblastic tumours may occur in a predisposition context. Two main genes are involved: PHOX2B, observed in familial cases and frequently associated with other neurocristopathies (Ondine's and Hirschsprung's disease); and ALK, mostly in familial tumours. We have assessed the frequency of mutations of these two genes in patients with a presumable higher risk of predisposition. We sequenced both genes in 26 perinatal cases (prebirth and <1 month of age, among which 10 were multifocal), 16 multifocal postnatal (>1 month) cases, 3 pairs of affected relatives and 8 patients with multiple malignancies. The whole coding sequences of the two genes were analysed in tumour and/or constitutional DNAs. We found three ALK germline mutations, all in a context of multifocal tumours. Two mutations (T1151R and R1192P) were inherited and shared by several unaffected patients, thus illustrating an incomplete penetrance. Younger age at tumour onset did not seem to offer a relevant selection criterion for ALK analyses. Conversely, multifocal tumours might be the most to benefit from the genetic screening. Finally, no PHOX2B germline mutation was found in this series. In conclusion, ALK deleterious mutations are rare events in patients with a high probability of predisposition. Other predisposing genes remain to be discovered.

摘要

神经母细胞瘤可能发生在易感性背景下。有两个主要基因参与:PHOX2B,见于家族性病例,常与其他神经嵴病变(翁迪恩氏病和先天性巨结肠)相关;ALK,主要见于家族性肿瘤。我们评估了这些两个基因在假定易感性较高的患者中的突变频率。我们对 26 例围产期病例(产前和<1 个月龄,其中 10 例为多灶性)、16 例多灶性产后(>1 个月)病例、3 对受累亲属和 8 例多发性恶性肿瘤患者的这两个基因进行了测序。对肿瘤和/或正常 DNA 中的两个基因的整个编码序列进行了分析。我们发现了三个 ALK 种系突变,均发生在多灶性肿瘤的背景下。两个突变(T1151R 和 R1192P)是遗传性的,为多个未受影响的患者所共有,因此说明存在不完全外显率。肿瘤发病年龄较轻似乎不是 ALK 分析的相关选择标准。相反,多灶性肿瘤可能最受益于基因筛查。最后,该系列未发现 PHOX2B 种系突变。总之,ALK 有害突变在易感性高的患者中是罕见事件。其他易感基因仍有待发现。

相似文献

1
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.神经母细胞瘤患者中的 ALK 胚系突变:一种罕见且弱外显的综合征。
Eur J Hum Genet. 2012 Mar;20(3):291-7. doi: 10.1038/ejhg.2011.195. Epub 2011 Nov 9.
2
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.神经母细胞瘤中配对样同源盒2B(PHOX2B)基因的种系突变。
Cancer Lett. 2005 Oct 18;228(1-2):51-8. doi: 10.1016/j.canlet.2005.01.055.
3
Identification of ALK as a major familial neuroblastoma predisposition gene.将ALK鉴定为主要的家族性神经母细胞瘤易感基因。
Nature. 2008 Oct 16;455(7215):930-5. doi: 10.1038/nature07261. Epub 2008 Aug 24.
4
Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation.两名具有明显临床表型的家族性神经母细胞瘤的兄弟姐妹携带有 ALK 种系突变。
Genes Chromosomes Cancer. 2018 Dec;57(12):665-669. doi: 10.1002/gcc.22676. Epub 2018 Oct 22.
5
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.神经母细胞瘤中配对样同源盒2B(PHOX2B)基因的种系突变。
Am J Hum Genet. 2004 Apr;74(4):761-4. doi: 10.1086/383253. Epub 2004 Mar 11.
6
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.神经母细胞瘤中ALK激酶受体的体细胞和生殖系激活突变。
Nature. 2008 Oct 16;455(7215):967-70. doi: 10.1038/nature07398.
7
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.神经母细胞瘤肿瘤进展分析;4p13上PHOX2B缺失和17q增益是神经母细胞瘤肿瘤发生的早期事件。
Int J Oncol. 2008 Mar;32(3):575-83.
8
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.PHOX2B 介导的 ALK 表达调控:体外鉴定两个神经母细胞瘤相关基因之间的功能关系。
PLoS One. 2010 Oct 1;5(10):e13108. doi: 10.1371/journal.pone.0013108.
9
Genetic susceptibility to neuroblastoma.神经母细胞瘤的遗传易感性。
Curr Opin Genet Dev. 2017 Feb;42:81-90. doi: 10.1016/j.gde.2017.03.008. Epub 2017 Apr 28.
10
Clinical feature of anaplastic lymphoma kinase-mutated neuroblastoma.间变性淋巴瘤激酶突变型神经母细胞瘤的临床特征。
J Pediatr Surg. 2012 Oct;47(10):1789-96. doi: 10.1016/j.jpedsurg.2012.05.007.

引用本文的文献

1
A review on optimization of Wilms tumour management using radiomics.关于使用放射组学优化肾母细胞瘤治疗的综述。
BJR Open. 2024 Oct 8;6(1):tzae034. doi: 10.1093/bjro/tzae034. eCollection 2024 Jan.
2
Identification of Mutation in Neuroblastoma on the Point of Molecular Heterogeneity.神经母细胞瘤分子异质性研究点的基因突变鉴定。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231211138. doi: 10.1177/15330338231211138.
3
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline F1174I Mutation.一名患有胚系F1174I突变的婴儿的多灶性神经母细胞瘤与中枢性通气不足
Diagnostics (Basel). 2022 Sep 19;12(9):2260. doi: 10.3390/diagnostics12092260.
4
Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring Rearrangement: A Case Report.携带重排的上皮样炎性肌纤维母细胞肉瘤对ALK酪氨酸激酶抑制剂的持久临床反应:一例报告
Front Oncol. 2022 Feb 14;12:761558. doi: 10.3389/fonc.2022.761558. eCollection 2022.
5
Molecular Genetics in Neuroblastoma Prognosis.神经母细胞瘤预后中的分子遗传学
Children (Basel). 2021 May 29;8(6):456. doi: 10.3390/children8060456.
6
Duplication of F1245 missense mutation due to acquired uniparental disomy associated with aggressive progression in a patient with relapsed neuroblastoma.复发性神经母细胞瘤患者中,由于获得性单亲二体导致F1245错义突变重复,与侵袭性进展相关。
Oncol Lett. 2019 Mar;17(3):3323-3329. doi: 10.3892/ol.2019.9985. Epub 2019 Jan 29.
7
Targeting anaplastic lymphoma kinase in neuroblastoma.靶向神经母细胞瘤中的间变性淋巴瘤激酶
APMIS. 2019 May;127(5):288-302. doi: 10.1111/apm.12940. Epub 2019 Apr 3.
8
Genetic susceptibility to neuroblastoma: current knowledge and future directions.神经母细胞瘤的遗传易感性:当前的认识和未来的方向。
Cell Tissue Res. 2018 May;372(2):287-307. doi: 10.1007/s00441-018-2820-3. Epub 2018 Mar 27.
9
Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.母体免疫:其在预防新生儿非感染性相关疾病中的应用新视角
Vaccines (Basel). 2017 Aug 1;5(3):20. doi: 10.3390/vaccines5030020.
10
Retinoblastoma and Neuroblastoma Predisposition and Surveillance.视网膜母细胞瘤和神经母细胞瘤的易感性和监测。
Clin Cancer Res. 2017 Jul 1;23(13):e98-e106. doi: 10.1158/1078-0432.CCR-17-0652.

本文引用的文献

1
Germline gain-of-function mutations of ALK disrupt central nervous system development.ALK 胚系获得性功能突变破坏中枢神经系统发育。
Hum Mutat. 2011 Mar;32(3):272-6. doi: 10.1002/humu.21442.
2
Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.间变性甲状腺癌中存在 ALK 基因的新型致癌突变。
Cancer Res. 2011 Jul 1;71(13):4403-11. doi: 10.1158/0008-5472.CAN-10-4041. Epub 2011 May 19.
3
Genomic imprinting syndromes and cancer.基因组印记综合征与癌症。
Adv Genet. 2010;70:145-75. doi: 10.1016/B978-0-12-380866-0.60006-X.
4
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification.神经母细胞瘤的荟萃分析显示,具有 MYCN 扩增的肿瘤中存在偏斜的 ALK 突变谱。
Clin Cancer Res. 2010 Sep 1;16(17):4353-62. doi: 10.1158/1078-0432.CCR-09-2660. Epub 2010 Aug 18.
5
A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.一种新的家族性癌症综合征,包括易患肾母细胞瘤和神经母细胞瘤。
Fam Cancer. 2010 Sep;9(3):425-30. doi: 10.1007/s10689-009-9319-8.
6
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective.髓母细胞瘤变体:年龄依赖性发生及其与戈林综合征的关系——一种新的临床视角
Clin Cancer Res. 2009 Apr 1;15(7):2463-71. doi: 10.1158/1078-0432.CCR-08-2023. Epub 2009 Mar 10.
7
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.晚期散发性神经母细胞瘤肿瘤中ALK基因的DNA突变和基因扩增发生率高。
Biochem J. 2008 Dec 1;416(2):153-9. doi: 10.1042/bj20081834.
8
Activating mutations in ALK provide a therapeutic target in neuroblastoma.间变性淋巴瘤激酶(ALK)中的激活突变在神经母细胞瘤中提供了一个治疗靶点。
Nature. 2008 Oct 16;455(7215):975-8. doi: 10.1038/nature07397.
9
Oncogenic mutations of ALK kinase in neuroblastoma.神经母细胞瘤中ALK激酶的致癌突变。
Nature. 2008 Oct 16;455(7215):971-4. doi: 10.1038/nature07399.
10
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.神经母细胞瘤中ALK激酶受体的体细胞和生殖系激活突变。
Nature. 2008 Oct 16;455(7215):967-70. doi: 10.1038/nature07398.